The Case Against the Annual Full Body Checkup

India's own rulebook says something smaller

Here is what almost nobody mentions in the festival-sale conversation. India already has a screening programme, run by the health ministry, and it looks nothing like the pamphlet. Under the National Programme for Prevention and Control of Non-Communicable Diseases, every Indian aged 30 and above is supposed to be screened once a year for two things: blood pressure and blood sugar. Common cancers get screened once every five years. That is the entire public-health schedule. Two checks, once a year, for the two silent killers. Not a 68-parameter panel.

The scale is worth pausing on. By August 2025, over 38.9 crore Indians had been screened for hypertension under the programme, with 5.13 crore diagnosed and 4.74 crore under treatment. Over 38.7 crore had been screened for diabetes, with 3.45 crore diagnosed. Those are enormous numbers, and they show something the pamphlet never will: the conditions that actually kill people quietly, blood pressure and blood sugar, are exactly the ones that earn a yearly slot. Everything else in the mega-package rides on their coattails.

The programme's logic is the same logic as the guidelines you will read about below. Screen the right people for the right things at the right intervals. When even the government programme, which has every incentive to look generous, keeps the annual list to two items, a 68-parameter private panel starts to look like what it is: a product, not a protocol.

182,880 people, 14 trials, zero extra years

The review that anchors everything here was done by the Nordic Cochrane Centre in Copenhagen and published in the BMJ in 2012. The researchers, led by Lasse Krogsboll, defined a health check the way the pamphlets do: screening a general population for more than one disease or risk factor across more than one organ system. Then they gathered every randomised trial that had tested whether inviting people to such checks changed anything. They found 16 trials; 14 had outcome data, covering 182,880 participants. The trials ran from 1963 to 1999, with a median follow-up of nine years. That is decades of evidence, not one study.

The headline numbers are worth reading slowly. For total mortality, nine trials with 155,899 participants and 11,940 deaths gave a risk ratio of 0.99, with a confidence interval of 0.95 to 1.03. For cardiovascular mortality, eight trials: 1.03 (0.91 to 1.17). For cancer mortality, eight trials: 1.01 (0.92 to 1.12).

In plain words, the checked group died at essentially the same rate as the unchecked group, and the confidence intervals rule out anything more than a trivial benefit. Subgroup and sensitivity analyses did not change the picture.

And here is the part the pamphlet industry skips. The checks did work at finding things. One trial found a 20 percent increase in the total number of new diagnoses per participant over six years compared with the control group. Another found more people labelled with hypertension and high cholesterol. Two of four trials that tracked prescriptions found more people put on blood-pressure drugs. So the machinery functioned exactly as advertised: more testing found more things. It just did not translate into more life. The researchers' conclusion was plain. General health checks did not reduce morbidity or mortality, neither overall nor for cardiovascular or cancer causes, although they increased the number of new diagnoses. Important harmful outcomes, they added, were often not studied or reported.

Krogsboll said it even more directly in interviews at the time. Public-health initiatives that systematically offer general health checks should be resisted. Not the tests themselves. The ritual of offering them to everyone, every year, as policy.

The world's guidelines walked away decades ago

The Cochrane review landed in 2012, but doctors' own rulebooks had walked away from the annual checkup long before that. In 1979, the Canadian Task Force on the Periodic Health Examination recommended against annual general checkups. A decade later, the US Preventive Services Task Force reviewed more than 6,000 studies covering over 200 interventions commonly performed at annual exams and reached the same place: an annual comprehensive history and head-to-toe physical was no longer strongly recommended for healthy adults. Both said the same thing in different words. Screen the right people for the right things at the right intervals, not everyone for everything once a year.

The American Medical Association's guidance at the time was even more specific. Healthy adults under 40 could safely go five years between exams. Older patients, every three years. The calendar everyone had treated as sacred was, officially, arbitrary.

In 2013, the Society of General Internal Medicine added its voice through the Choosing Wisely campaign: do not perform routine general health checks for asymptomatic adults. The rationale cited the Cochrane review directly. The checks had not been shown to reduce illness, death, or hospital visits, and they created potential harm from unnecessary testing. A decade later, in 2023, the society revised the guidance with researchers from Northwestern University, and the revision is instructive. The exceptions prove the rule. Annual checkups are still worth it for people aged 65 and above, people with low self-rated health, people with overdue preventive services, and people who rarely see a doctor. If you are none of those, the ritual is not earning its keep.

Britain took yet another path. The NHS Health Check, running since 2009, invites adults aged 40 to 74 once every five years. Not annually. The check is short on purpose: blood pressure, a finger-prick cholesterol test, weight and height, lifestyle and family-history questions, and a ten-year risk score for heart disease, stroke, diabetes, and kidney disease. Notice the pattern across every one of these guidelines. Not one of them says sixty parameters, every twelve months.

Three ways a big panel works against you

So why does the annual mega-package persist? Because it sells. But persistence is not safety, and the big panels have three real problems that the guidelines keep pointing at.

First, more labels, not more life. This is the overdiagnosis problem the Cochrane researchers flagged. A borderline number that would never have caused trouble gets flagged in red. The red flag triggers a repeat test, maybe a specialist visit, sometimes a procedure. Each step feels like diligence. But the starting point was a healthy person, and the endpoint is a person who now takes a pill or carries a diagnosis for something that might never have mattered. Finding more disease without saving more lives means you are probably over-diagnosing and over-treating. That was the researchers' own reading of their results.

Second, the arithmetic of false positives. No test is perfect, and a 68-parameter panel makes that imperfection a near certainty. Think about it this way. If each test is right 95 percent of the time for a healthy person, running 68 of them means the odds of at least one wrong red flag are overwhelming.

On a big enough panel, one odd result is almost guaranteed by statistics alone. That is how a healthy 34-year-old ends up spending a week worrying about a mildly off liver value that a repeat draw, done calmly, shows was nothing. The worry is not a side effect. It is the product working as designed.

Third, false reassurance. This is the one nobody talks about. A clean report in January does not protect you in July. Patients sometimes treat a normal annual report like a warranty card, valid for twelve months, and postpone seeing a doctor when something new appears because "my checkup was fine." A report is a snapshot, not a shield. Nothing found that day is good news, not immunity.

None of these three problems exist because tests are bad. They exist because testing without a reason multiplies noise faster than signal.

The short list that actually earns its place

Here is the part the pamphlet gets backwards. The tests that matter are not the exotic ones. They are the boring ones, done on the schedule the guidelines actually recommend. A lipid profile checked about every five years catches the cholesterol that builds up quietly for years. Fasting blood sugar, or its three-month-average cousin HbA1c, catches the diabetes that brews silently long before the thirst starts. A complete blood count catches anaemia, infection signals, and platelet problems in one draw. And blood pressure, measured properly, catches the condition with no symptoms at all until it damages something.

The schedules come from guidelines, not from a package designer counting parameters to justify a price.

Blood pressure: the US task force recommends screening all adults from age 18. From 40 onwards, yearly checks make sense. For adults aged 18 to 39 with normal readings and no extra risk, every three to five years is enough. This is the single most valuable screening most adults get, and it takes two minutes with a cuff.

Cholesterol: about every five years is the reasonable interval, starting at 35 for men and 45 for women under the US guidance, earlier if you carry extra weight, smoke, or have heart disease in the family. Lipid numbers move slowly. Checking them yearly adds cost and worry without adding information.

Blood sugar: the American Diabetes Association says screening should start at 35 for everyone, and be repeated at least every three years if results are normal. If you land in the prediabetes zone (A1C between 5.7 and 6.4 percent), testing goes yearly, because that is the window where lifestyle changes actually reverse the course. The US task force adds a striking detail: the number of people you need to screen to find one case of diabetes drops sharply after 35, from 80 in the early thirties to 31 in the late thirties. That is why 35 is the line.

One note, since it confuses people: exact cutoffs and reference ranges vary by laboratory and by the method used. What matters is the schedule and the trend, not whether one number sits a hair above a printed range.

Notice what this short list costs compared with the mega-package. One blood draw covers the CBC, the lipid profile, and the sugar tests together. The value was never in the count. It was in the timing.

Your screening calendar, decade by decade

Guidelines do not hand you one schedule for life. They hand you a schedule that changes as your risk changes. Here is how it breaks down, in plain terms.

In your twenties, if you feel fine, there is almost nothing you need on a schedule. Get your blood pressure checked when you happen to see a doctor. That is it. The Indian health ministry's programme starts its annual screening at 30, not 20, for a reason. A healthy 25-year-old buying a 68-parameter package is paying for noise.

In your thirties, the picture shifts. Blood pressure becomes a yearly check. This is also when cholesterol earns its first baseline reading, especially if you carry extra weight, smoke, or have a parent who had heart trouble young. Blood sugar screening enters the picture earlier than most people expect: 35 for everyone, earlier with extra weight or diabetes in the family. Patients often ask us at the counter whether they should wait for symptoms. With blood sugar and blood pressure, waiting for symptoms means waiting for damage. These two have no early warning system. That is precisely why they are on every guideline's list.

In your forties, the schedule firms up. Blood pressure yearly. Cholesterol about every five years. Blood sugar every three years if normal. This is also the decade when the NHS, for its part, starts inviting people for its five-yearly check. The forties are when silent conditions start showing up in reports, and when catching them actually changes the next twenty years. A single fasting draw at our lab covers the sugar and lipid numbers together, and the report lands in about 24 hours.

In your fifties and beyond, you add the cancer screenings your doctor recommends for your sex and risk, and this is where the 2023 revision of the Choosing Wisely guidance quietly brings the annual checkup back. At 65 and above, or with low self-rated health, or with preventive care long overdue, a yearly visit is genuinely worthwhile. The difference is that by then the visit has a purpose. It is targeted at your actual risks, not at a pamphlet's parameter count.

The pattern is the whole argument in miniature. Screening grows with age and risk. It never meant buying the same fixed bundle at 28 and at 58.

If you buy it, buy it like this

Let us be realistic. Plenty of people will still buy a package, because the SMS arrived, because the company reimburses it, or because the peace of mind feels worth the money. There is nothing wrong with that. Just buy it with your eyes open.

• Do: size the package to your age and risk, not to the parameter count. The Full Body Checkup - Essential covers 61 parameters and the Advanced covers 68. The difference between them is breadth, not medical necessity. A healthy 32-year-old gains nothing from the longer list.

• Do: bring last year's report when you come. Trends beat snapshots. A cholesterol number that has crept up three years in a row tells your doctor more than any single red flag.

• Do: repeat any borderline red flag before believing it. Labs say ranges vary for a reason: hydration, a heavy meal the night before, a tough week, all move numbers. One odd line is a question, not a diagnosis.

• Do: read the fine print on what is actually included. Some packages count each CBC component as a separate "parameter." Sixty-eight can mean twenty tests with fancy counting.

• Don't: buy because the SMS said "last day of offer." The offer will be back next month. It always is.

• Don't: assume a bigger parameter count means better care. The Cochrane review found that more testing produced more labels, not more life.

• Don't: treat a normal report as a twelve-month warranty. If something new appears in March, see a doctor in March, not at your next annual date.

• Don't: chase every red line with a specialist visit. Ask your doctor first whether one odd value needs a repeat, a retest in a few weeks, or nothing at all.

And if the package question is really "which tests do I need," the answer is the short list from the section above, not the pamphlet. Our tests page lists everything individually, and packages shows what each bundle contains, so you can compare without the sales language.

Questions patients ask us at the counter

Is an annual checkup harmful, or just a waste of money? Potentially both. Beyond the money, one incidental finding can start a cascade: repeats, scans, specialist visits, sometimes procedures nobody needed. The Cochrane reviewers noted that harmful outcomes were often not even studied. The risk is not zero, and the benefit, across 182,880 people, was.

My company offers a free annual package. Should I still go? Free changes the math completely. Go. Just treat the report with calm skepticism. Repeat borderline red flags before worrying, and ask your doctor whether one odd line needs anything at all. A free snapshot is useful. A free snapshot is not a medical plan.

If everything comes back normal, am I safe for a year? No. A report is a photograph of one morning. Blood pressure can climb, sugar can drift, and new symptoms can appear months after a clean report. "Nothing found that day" is good news. It is not a shield.

At what age should regular screening start? Blood pressure checks from your late teens, yearly from your thirties or forties. Cholesterol baseline around 35 to 45, then about every five years. Blood sugar from 35, every three years if normal. India's own programme starts annual BP and sugar screening at 30. Under 30 and healthy, see a doctor when something feels wrong, not a package when nothing does.

I am under 30 and feel fine. Do I need any tests at all? Almost certainly not on a schedule. The guidelines agree here: no task force recommends routine blood panels for healthy twenty-somethings. Save the money. If something feels off, that is what doctors are for.

My last package flagged one borderline value. Does that mean I am ill? Probably not. Reference ranges are drawn so that a small slice of healthy people falls outside them on any given test. On a 68-parameter panel, at least one healthy person in every batch will collect a red flag by pure statistics. Repeat the test, calmly, before anything else.

Can I skip the doctor and just order the package myself? You can, and many people do. But the package cannot interpret itself. The value of a checkup was never the blood draw; it was a clinician looking at your numbers in the context of your body, your family, and your history. A report without that context is data, not advice.

Diabetes or heart disease runs in my family. Does the yearly package make sense then? Family history changes which tests you need, not whether you need all of them yearly. It usually means starting blood sugar or cholesterol screening earlier and repeating the relevant ones on schedule. Ask your doctor to build the list around your actual risk. That targeted list will beat any fixed bundle.

How do I pick between the Essential and Advanced packages? Look at what the extra parameters actually are, not the count. For most adults under 40 with no risk factors, the Essential covers the meaningful ground. The Advanced adds breadth that matters more with age, symptoms, or specific risks your doctor has flagged. When in doubt, the smaller package plus a conversation with your doctor beats the bigger package alone.

Is home collection as accurate as giving blood at the lab? Yes. The phlebotomist follows the same protocol at your doorstep: the tourniquet, the alcohol swab, the quick needle prick that stings for a second, the tubes filled in order, the cotton ball pressed to your arm. The samples travel in the same sealed, temperature-controlled carriers to the same lab and run on the same analysers. What changes is your morning, not the result. Our home collection covers Malad, Kandivali, Borivali, and Goregaon, and the lab itself runs 24x7.

So what should you do instead?

Think servicing, not festival ritual. You do not service a car by replacing every part once a year. You check what wears out, when it wears out. Your body works the same way. Blood pressure, every year from your thirties or forties. Cholesterol, about every five years. Blood sugar, from 35, every three years if normal. That is the entire maintenance schedule for most healthy adults, and it fits in a single blood draw plus a cuff reading.

If you want the convenience of a package, fine. Pick the one sized to your age and risk, get the draw done at home or at the lab, and read the report as a snapshot with a trend line. Bring the previous year's report. Repeat the borderline lines. And when something new appears between checkups, see a doctor then. The calendar is not a medical instrument. Your attention is.

If you do book, one draw covers the CBC, lipid profile, and sugar tests together. Call 84250 40353. The lab never closes, home collection across Malad, Kandivali, Borivali, and Goregaon costs nothing extra, and reports land in about 24 hours.

The argument in one paragraph: 14 trials and 182,880 people found that general health checks do not cut deaths. Guidelines in Canada, the US, and the UK all favour targeted, risk-based screening over a fixed yearly bundle. India's own programme screens everyone over 30 yearly for blood pressure and blood sugar, and nothing else. A few simple tests on the right schedule catch the real silent risks. If you buy a package, buy it for your body, not the pamphlet.

References

Krogsboll LT et al. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ 2012;345:e7191.

Society of General Internal Medicine. Choosing Wisely: do not perform routine general health checks for asymptomatic adults (2013; revised 2023).

NHS Health Check programme, England: five-yearly checks for adults aged 40 to 74 (blood pressure, cholesterol, BMI, lifestyle review, 10-year risk score).

National Programme for Prevention and Control of Non-Communicable Diseases, Ministry of Health and Family Welfare, Government of India: annual screening of population aged 30+ for hypertension and diabetes; five-yearly screening for common cancers (PIB release, August 2025).